Bernstein Joel E. 4
4 · Winston Pharmaceuticals, Inc. · Filed Apr 15, 2009
Insider Transaction Report
Form 4
Bernstein Joel E.
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock Options
2009-04-07+100,000→ 100,000 totalExercise: $1.53Exp: 2019-04-07→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Such options vest in five equal annual installments, commencing 04/07/2010.
- [F2]Reported amount excludes options to purchase 661,913 shares of the Company's common stock, initially exercisable on 04/06/2006 and expiring on 04/06/2010, at an exercise price of $0.37.